JP2012506861A5 - - Google Patents

Download PDF

Info

Publication number
JP2012506861A5
JP2012506861A5 JP2011533328A JP2011533328A JP2012506861A5 JP 2012506861 A5 JP2012506861 A5 JP 2012506861A5 JP 2011533328 A JP2011533328 A JP 2011533328A JP 2011533328 A JP2011533328 A JP 2011533328A JP 2012506861 A5 JP2012506861 A5 JP 2012506861A5
Authority
JP
Japan
Prior art keywords
composition
therapeutic agent
pellet
prepared
debranched starch
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2011533328A
Other languages
English (en)
Japanese (ja)
Other versions
JP2012506861A (ja
JP5608167B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2009/061662 external-priority patent/WO2010048389A2/en
Publication of JP2012506861A publication Critical patent/JP2012506861A/ja
Publication of JP2012506861A5 publication Critical patent/JP2012506861A5/ja
Application granted granted Critical
Publication of JP5608167B2 publication Critical patent/JP5608167B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2011533328A 2008-10-23 2009-10-22 加工デンプンを含む医薬ペレット、およびそれの治療への応用 Expired - Fee Related JP5608167B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US10778408P 2008-10-23 2008-10-23
US61/107,784 2008-10-23
PCT/US2009/061662 WO2010048389A2 (en) 2008-10-23 2009-10-22 Pharmaceutical pellets comprising modified starch and therapeutic applications therefor

Publications (3)

Publication Number Publication Date
JP2012506861A JP2012506861A (ja) 2012-03-22
JP2012506861A5 true JP2012506861A5 (enExample) 2012-12-06
JP5608167B2 JP5608167B2 (ja) 2014-10-15

Family

ID=42118112

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2011533328A Expired - Fee Related JP5608167B2 (ja) 2008-10-23 2009-10-22 加工デンプンを含む医薬ペレット、およびそれの治療への応用

Country Status (9)

Country Link
US (2) US20100105784A1 (enExample)
EP (1) EP2344121B1 (enExample)
JP (1) JP5608167B2 (enExample)
KR (1) KR20110073618A (enExample)
CN (1) CN102202648B (enExample)
BR (1) BRPI0919869A2 (enExample)
RU (1) RU2519715C2 (enExample)
TW (1) TWI500429B (enExample)
WO (1) WO2010048389A2 (enExample)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK2334378T3 (da) 2008-08-19 2014-07-07 Xenoport Inc Prodrugs af methylhydrogenfumarat, farmaceutiske sammensætninger deraf og fremgangsmåder til anvendelse
KR20160112012A (ko) * 2011-05-02 2016-09-27 아데어 파마슈티컬스 인코포레이티드 질내 투여용 속용성 정제 조성물
US20140348915A9 (en) 2012-08-22 2014-11-27 Xenoport, Inc. Oral Dosage Forms of Methyl Hydrogen Fumarate and Prodrugs Thereof
JP2015527372A (ja) 2012-08-22 2015-09-17 ゼノポート，インコーポレイティド 副作用を低減させるモノメチルフマレートおよびそのプロドラッグの投与方法
WO2014160633A1 (en) 2013-03-24 2014-10-02 Xenoport, Inc. Pharmaceutical compositions of dimethyl fumarate
US9302977B2 (en) 2013-06-07 2016-04-05 Xenoport, Inc. Method of making monomethyl fumarate
US9421182B2 (en) 2013-06-21 2016-08-23 Xenoport, Inc. Cocrystals of dimethyl fumarate
TW201516020A (zh) 2013-09-06 2015-05-01 Xenoport Inc （ｎ，ｎ－二乙基胺甲醯基）甲基（２ｅ）丁－２－烯－１，４－二酸甲酯之晶形、合成方法及用途
US9999672B2 (en) 2014-03-24 2018-06-19 Xenoport, Inc. Pharmaceutical compositions of fumaric acid esters
WO2019213473A1 (en) * 2018-05-04 2019-11-07 The Procter & Gamble Company Compositions and methods for treating vaginal dryness

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8723846D0 (en) * 1987-10-10 1987-11-11 Danbiosyst Ltd Bioadhesive microsphere drug delivery system
CH678697A5 (enExample) * 1989-04-03 1991-10-31 Warner Lambert Co
US5468286A (en) * 1989-10-25 1995-11-21 National Starch And Chemical Investment Holding Corporation Enzymatically debranched starches as tablet excipients
US5281276A (en) * 1992-03-25 1994-01-25 National Starch And Chemical Investment Holding Corporation Process for making amylase resistant starch from high amylose starch
US5260068A (en) * 1992-05-04 1993-11-09 Anda Sr Pharmaceuticals Inc. Multiparticulate pulsatile drug delivery system
NL9201195A (nl) * 1992-07-03 1994-02-01 Tno Preparaat voor de gereguleerde afgifte van een werkzame stof en werkwijze ter bereiding van een dergelijk preparaat.
CA2211778A1 (en) * 1997-08-14 1999-02-14 Francois Carriere Preparation of pregelatinized high amylose starch and debranched starch useful as an excipient for controlled release of active agents
ES2224642T3 (es) * 1998-04-22 2005-03-01 Glycologic Limited Composiciones administrables por via oral, que comprenden un polisacarido reticulado por un carton y un polimero digerible en el tracto gastrointestinal inferior.
US7262170B2 (en) * 1998-04-26 2007-08-28 Zhongming Zeng Pharmaceutical composition for reducing vaginal acidity and treatment of vaginitis, and the use thereof
US7238677B2 (en) * 2003-03-28 2007-07-03 Kimberly-Clark Worldwide, Inc. Prevention of urogenital infections
US7276486B2 (en) * 2004-03-15 2007-10-02 Kimberly-Clark Worldwide, Inc. Compositions for vaginal treatment
US20050214364A1 (en) * 2004-03-23 2005-09-29 Hutman Herbert W Products and methods for treating vaginal infections
US8318230B2 (en) * 2005-05-02 2012-11-27 Henkel Ag & Co. Kgaa Use of debranched starch in extrusion-spheronization pharmaceutical pellets
BRPI0602614A (pt) * 2005-05-02 2006-12-26 Nat Starch Chem Invest utilização de amido desramificado na extrusão - esferonização de pelotas farmacêuticas
EP1872775A1 (en) * 2006-06-29 2008-01-02 Polichem S.A. Use of a hydrophilic matrix comprising a polyacrylic acid derivative, a cellulose ether and a disintegrant for the manufacture of a medicament for treating female genital disorders

Similar Documents

Publication Publication Date Title
JP2012255026A5 (enExample)
JP2010535814A5 (enExample)
WO2011111027A3 (en) Oral dispersible delayed release tablet formulation
RU2011120438A (ru) Фармацевтические гранулы, содержащие модифицированный крахмал, и их терапевтические применения
WO2011107855A3 (en) Sustained release oral liquid suspension dosage form
WO2011115969A3 (en) Process of manufacturing a lyophilized fast dissolving, muti-phasic dosage form
JP2015510928A5 (enExample)
JP2010534236A5 (enExample)
JP2009256374A5 (enExample)
PE20110583A1 (es) Comprimidos de capecitabina de disgregacion rapida
JP2012167125A5 (enExample)
JP2009537554A5 (enExample)
JP2011026335A5 (enExample)
AR086249A1 (es) Composiciones de tabletas de disolucion rapida de administracion vaginal
RU2014142025A (ru) Препарат длительного высвобождения для снижения частоты мочеиспускания и способ его применения
WO2011037976A3 (en) Pramipexole pharmaceutical formulations
WO2015038552A3 (en) Aspirin formulation for increased efficacy
JP2009522376A5 (enExample)
JP2011515391A5 (enExample)
ECSP12012360A (es) Preparación recubierta con partículas finas
WO2014181195A3 (en) Antiemetic extended release solid dosage forms
JP2008531710A5 (enExample)
JP2015129124A5 (enExample)
CN201257161Y (zh) 复方单硝酸异山梨酯双释胶囊
JP2019529572A5 (enExample)